Participation in Summary Proceedings from the CRS 2025 Annual Meeting, Philadelphia

The Faculty of Life and Allied Health Sciences (FLAHS) extends its heartfelt appreciation to Dr. Sahadev Shankarappa, Professor in the Department of Biotechnology, for his exemplary representation of the Biotechnology department at the Controlled Release Society (CRS) 2025 Annual Meeting in Philadelphia.

Dr. Shankarappa represented Ramaiah University of Applied Sciences at the meeting, held in Philadelphia, USA, where he presented key research findings from his lab group. His work highlighted the use of axonal pathways for delivering ligand-functionalized nanoparticles to sensory neurons—a strategy with significant potential for the targeted treatment of neurological conditions such as chronic pain. The talk drew considerable interest from experts in neural drug delivery, prompting valuable discussions on uptake mechanisms in high-curvature systems like axons. In a separate session, 'CRS Around the World,' RUAS's research on deep learning-based quantification of C. elegans behavior for nanoparticle toxicity screening was also presented. This innovative approach, developed in collaboration with OrangeHue Life Sciences, attracted attention as a scalable tool for early-stage toxicity evaluation.

Dr. Shankarappa also engaged with global researchers working on RNA therapeutics, biomaterials, 3D bioprinting, and gut-targeted delivery systems, reflecting RUAS’s commitment to innovation in translational biomedical science. His participation was supported by a travel grant from the Anusandhan National Research Foundation and the Controlled Release Society, India Chapter.